The Opportunity
Eunice Healthcare with its experience in the clinical
laboratory and research markets, will introduce your products to
the European laboratory market.
European countries have many approaches but there is one common
factor in the area of healthcare - the need to have CE-marking
on in vitro diagnostic (IVD) products. The European Union’s IVD
Directive, applied in December 2003, mandates that
all IVD devices used in the human, clinical setting must be registered
and have a CE-symbol affixed.
It is also a requirement that non-EU IVD manufacturers that do
not have an establishment or affiliate in Europe must appoint an
Authorized Representative who is domiciled in the European Union.
These regulations do not apply to reagents used in an evaluation
or research setting.
Eunice Healthcare will ensure that your quality system meets the
requirements of the IVD Directive, will register your products
and will provide you with the outlets to sell your products.
The markets in Europe are fragmented between public and private
sectors, by medical traditions and by reimbursement and funding
policies. This is where the experience and local knowledge of Eunice
Healthcare will ensure the success of your products in Europe.
The EDMA (European Diagnostic
Manufacturers’ Association) 2006 Report has evaluated the
total IVD market in Europe at over $9 billion. Moreover,
an ageing populations and the ever-increasing demand for state-of-the-art
medical care has ensured a continuing, annual growth of over 5%
in the European IVD market in recent years. EDMA
2006 data (PDF) show particularly strong growth in the areas
of testing associated with cardiac markers and diabetes.
The Obstacles
European countries display an amazing multiplicity of approaches
in the area of healthcare. The IVD markets in the various countries
are fragmented between public and private sectors, by medical traditions,
and not least, by reimbursement policies.
With the application of the IVD Directive in December 2003, the
European Union (EU) has mandated that all IVD devices for use in
the human clinical setting must be registered and have the CE-mark
affixed. Each EU country and certain other states (e.g.,
Switzerland) have mandated the languages that
are acceptable for the IVD product labeling in that country.
It is also a requirement that non-EU IVD manufacturers that do
not have an establishment or affiliate in Europe must appoint an
Authorized Representative who is domiciled in the European Union.
The Solution
Eunice Healthcare provides you with solutions for both
the regulatory and commercial aspects of bringing your products
successfully to the European market.
As your Authorized Representative, Eunice Healthcare will:
- Ensure your quality system and files meet the essential requirements
of the IVD Directive
- Insure the translation of product labeling into appropriate
languages
- Interact with the relevant Notified Body for Annex
II products ((PDF document; 80K)
- Register products with the appropriate Competent
Authority (link to web site)
- Maintain files for inspection when requested by the Competent
Authority
- Perform post-market vigilance
- Advise on changing regulatory requirements
As your Commercial Representative, Eunice Healthcare will:
- Appoint distributors
- Organize product training
- Co-ordinate orders
- Arrange logistics
- Manage receivables
To explore your needs for entering the European market, please
contact us for a
discussion on how Eunice Healthcare can help you succeed in Europe.
|